Ro vs Hims
Side-by-side comparison of Ro and Hims for compounded tirzepatide and semaglutide: advertised price vs true monthly cost, 12-month totals, membership, cancellation terms, medications offered and who each is best for.
The short version
- Ro has a verified tirzepatide price in our database ($4,977 for 12 months, all-in). Hims's current tirzepatide price is pending direct verification, so we do not rank the pair on cost yet.
- Neither provider's current semaglutide price has been directly verified yet, so this comparison is structural rather than a cost ranking.
- Ro is the reference point for brand-name and insurance pathways rather than for lowest cash price.
- Hims competes on brand recognition and prepaid semaglutide pricing rather than on tirzepatide.
Head-to-head answers
- Which is cheaper over a year? Cannot be answered yet: Hims has no rankable price.
- Which is cheaper month-to-month at maintenance doses? Only Ro publishes a month-to-month price ($449).
- Which has no membership fee? Ro: not confirmed. Hims: $149/mo.
- Which uses which pharmacy? Ro: LillyDirect (Zepbound vials), NovoCare Pharmacy (Wegovy). Hims: not named.
- Which is better at the maintenance dose? Ro: price rises with dose. Hims: higher-dose price not published.
- Which requires a video visit? Ro: asynchronous-first. Hims: asynchronous.
- Which accepts insurance? Ro: yes, for brand medication. Hims: cash-pay.
- Which has better cancellation terms? Ro: Cancel anytime. Hims: Cancel anytime; prepaid plans are not refunded mid-term.
- Which is better for switching at an established dose? Neither clearly: confirm the price at your dose and whether the prescriber will continue it.
Hims
Pricing pending verification. Hims's current weight-loss page uses a service-membership model ($39 the first month, then $149 per month) with medication billed separately and a product mix emphasizing FDA-approved brands including the Wegovy pill. The legacy $165 compounded annual offer is not on the current page and has been withdrawn from our rankings. Verified against the provider's own pages on 2026-09-04 (first-party verification pass).
Side by side
Green cells mark the better value on that row when both figures are known. * provisional score: pricing not yet directly verified.
Pricing in words
Ro charges $299 per month at the starting dose, rising to $449 per month at higher doses for brand-name tirzepatide (pen). Whether a separate program or membership fee applies has not been confirmed. On our all-in basis, the lowest true monthly cost is $299 and the lowest 12-month total is $4,977 (month-to-month plan). Because pricing rises with dose, the 12-month figure uses our 3 + 9 titration model (three months at the starting price, nine at the maintenance price). Prices last checked September 4, 2026; status: verified.
Ro offers compounded semaglutide, but we have not yet verified its current price directly, so it is listed without a ranked price. Verification status: unverified.
Hims offers compounded semaglutide, but we have not yet verified its current price directly, so it is listed without a ranked price. Verification status: unverified.
Choose Ro if
Patients with insurance that may cover Wegovy or Zepbound, or who specifically want FDA-approved brand medication.
- Strongest insurance-navigation service among the providers we track
- FDA-approved brand-name medication (Wegovy, Zepbound) as the default pathway
- Large, well-capitalized telehealth operator with 50-state coverage
Choose Hims if
Men comfortable prepaying a year for compounded semaglutide from a large, well-known telehealth brand.
- Largest consumer telehealth brand with 50-state coverage and in-house pharmacy capacity
- All-in monthly pricing that includes provider access and shipping
- Offers oral compounded GLP-1 options
What to weigh against each
Ro: Program fee is billed separately from medication, and brand-name self-pay prices are far above compounded prices. Compounded pricing has changed repeatedly since the shortages ended. Requires more steps (insurance checks, prior authorization) than compounded-only providers.
Hims: Lowest advertised rate typically requires paying 12 months up front. Did not offer compounded tirzepatide as of our last check. Its 2025 brand-name Wegovy partnership with Novo Nordisk ended within months. $149 monthly membership excludes medication; the all-in cost depends on which product is prescribed and at what price.
How to read this comparison
Both providers were scored with the same rubric and the same cost model. Rankings never use the advertised monthly price on its own, because a low first-month number can hide a membership fee or a dose-based increase. Where a provider's price has not been directly checked against its own site, we say so and do not rank it on cost. Compounded tirzepatide and semaglutide are not FDA-approved; the only FDA-approved products are Zepbound, Mounjaro, Wegovy, Ozempic and Rybelsus. See the methodology and important safety information.
Frequently asked questions
Is Ro cheaper than Hims?
Ro has a verified tirzepatide price in our database ($4,977 for 12 months, all-in). Hims's current tirzepatide price is pending direct verification, so we do not rank the pair on cost yet.
Does Ro or Hims charge a membership fee?
Ro: a separate program fee whose amount is pending verification. Hims: membership of $149.00 per month.
Which is better for tirzepatide, Ro or Hims?
Ro offers tirzepatide; Hims does not offer tirzepatide. Ro is the reference point for brand-name and insurance pathways rather than for lowest cash price. Hims competes on brand recognition and prepaid semaglutide pricing rather than on tirzepatide.